<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gillrie MR</submitter><funding>NIAID NIH HHS</funding><pagination>3426-35</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2200906</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>110(9)</volume><pubmed_abstract>Pulmonary complication in severe Plasmodium falciparum malaria is manifested as a prolonged impairment of gas transfer or the more severe acute respiratory distress syndrome (ARDS). In either clinical presentation, vascular permeability is a major component of the pathologic process. In this report, we examined the effect of clinical P falciparum isolates on barrier function of primary dermal and lung microvascular endothelium in vitro. We showed that parasite sonicates but not intact infected erythrocytes disrupted endothelial barrier function in a Src-family kinase-dependent manner. The abnormalities were manifested both as discontinuous immunofluorescence staining of the junctional proteins ZO-1, claudin 5, and VE-cadherin and the formation of interendothelial gaps in monolayers. These changes were associated with a loss in total protein content of claudin 5 and redistribution of ZO-1 from the cytoskeleton to the membrane and the cytosolic and nuclear fractions. There was minimal evidence of a proinflammatory response or direct cellular cytotoxicity or cell death. The active component in sonicates appeared to be a merozoite-associated protein. Increased permeability was also induced by P falciparum glycophosphatidylinositols (GPIs) and food vacuoles. These results demonstrate that parasite components can alter endothelial barrier function and thus contribute to the pathogenesis of severe falciparum malaria.</pubmed_abstract><journal>Blood</journal><pubmed_title>Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins.</pubmed_title><pmcid>PMC2200906</pmcid><funding_grant_id>AI 41139</funding_grant_id><funding_grant_id>R01 AI041139</funding_grant_id><pubmed_authors>Gowda DC</pubmed_authors><pubmed_authors>Ho M</pubmed_authors><pubmed_authors>Gillrie MR</pubmed_authors><pubmed_authors>Looareesuwan S</pubmed_authors><pubmed_authors>Lee K</pubmed_authors><pubmed_authors>Buret AG</pubmed_authors><pubmed_authors>Krishnegowda G</pubmed_authors><pubmed_authors>Robbins SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins.</name><description>Pulmonary complication in severe Plasmodium falciparum malaria is manifested as a prolonged impairment of gas transfer or the more severe acute respiratory distress syndrome (ARDS). In either clinical presentation, vascular permeability is a major component of the pathologic process. In this report, we examined the effect of clinical P falciparum isolates on barrier function of primary dermal and lung microvascular endothelium in vitro. We showed that parasite sonicates but not intact infected erythrocytes disrupted endothelial barrier function in a Src-family kinase-dependent manner. The abnormalities were manifested both as discontinuous immunofluorescence staining of the junctional proteins ZO-1, claudin 5, and VE-cadherin and the formation of interendothelial gaps in monolayers. These changes were associated with a loss in total protein content of claudin 5 and redistribution of ZO-1 from the cytoskeleton to the membrane and the cytosolic and nuclear fractions. There was minimal evidence of a proinflammatory response or direct cellular cytotoxicity or cell death. The active component in sonicates appeared to be a merozoite-associated protein. Increased permeability was also induced by P falciparum glycophosphatidylinositols (GPIs) and food vacuoles. These results demonstrate that parasite components can alter endothelial barrier function and thus contribute to the pathogenesis of severe falciparum malaria.</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Nov</publication><modification>2025-04-22T12:54:42.981Z</modification><creation>2019-03-27T02:43:47Z</creation></dates><accession>S-EPMC2200906</accession><cross_references><pubmed>17693580</pubmed><doi>10.1182/blood-2007-04-084582</doi></cross_references></HashMap>